EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

Javier Donate-Correa, Ernesto Martín-Núñez iD, Carolina Hernández-Carballo, Ainhoa González-Luis, Carmen Mora-Fernández, Alberto Martín-Olivera, Sergio Rodríguez-Ramos iD, Purificación Cerro-López, Ángel López-Castillo, Alejandro Delgado-Molinos, Victoria Castro López-Tarruella, Juan F Navarro-González iD

International Journal of Molecular Sciences · 17.05.2024 · 25 (10) · 5457

DOI: 10.3390/ijms25105457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.05.2024. Verfasst von Javier Donate-Correa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit, University Hospital Nuestra Señora de Candelaria (UHNSC), 38010 Santa Cruz de Tenerife, Spain. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Renal Insufficiency, Chronic, Peripheral Arterial Disease, Fibroblast Growth Factors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ISCIII, FIISC, FCMG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast growth factor 23 (FGF23) levels are often elevated in chronic kidney disease (CKD). FGF23 and inflammation are common characteristics in CKD, and both are associated with worse disease progression and the occurrence of complications. The existence of an interaction between FGF23 and inflammation has been suggested, each of which influences the expression and activity of the other, leading to a vicious feedback loop with adverse outcomes, including cardiovascular disease and mortality. In this work, we determined circulating FGF23 levels in a group of patients with CKD stages 3 and 4 subjected to elective femoral endarterectomy due to established peripheral artery disease (PAD), a condition resulting from an athero-inflammatory process, and we studied its associations with different inflammatory markers and mediators. We evaluated its association with serum tumor necrosis factor (TNF)α, interleukin (IL) 6, and IL10, as well as with the gene expression levels of these parameters and A disintegrin and metalloproteinase domain-containing protein (ADAM) 17 in femoral vascular tissue and peripheral blood circulating cells (PBCCs). We also analyzed its association with serum concentrations of C-reactive protein (CRP), the systemic immune inflammation index (SII), and the neutrophil-to-lymphocyte ratio (NLR). Finally, we determined the vascular immunoreactivity of protein TNFα in a subgroup of patients. FGF23 concentrations were independently associated with circulating and PBCC mRNA levels of TNFα. Worst kidney function and diabetes were also found to be contributing to FGF23 levels. Patients with higher levels of FGF23 also had greater vascular immunoreactivity for TNFα.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23Renal Insufficiency, ChronicPeripheral Arterial DiseaseFibroblast Growth FactorsHumansMaleFemaleAgedMiddle AgedTumor Necrosis Factor-alphaBiomarkersC-Reactive ProteinADAM17 ProteinInterleukin-6Interleukin-10Inflammation

Stichwörter der Autor:innen

atherosclerosischronic kidney diseasefibroblast growth factor 23inflammationperipheral artery disease

Substanzen

FGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsTumor Necrosis Factor-alphaBiomarkersC-Reactive ProteinADAM17 ProteinInterleukin-6Interleukin-10

Autor:innen und Institutionen

  • Research Unit, University Hospital Nuestra Señora de Candelaria (UHNSC), 38010 Santa Cruz de Tenerife, Spain.
  • GEENDIAB (Grupo Español Para el Estudio de la Nefropatía Diabética), Sociedad Española de Nefrología, 39000 Santander, Spain.
  • Instituto de Tecnologías Biomédicas, Universidad de La Laguna, 38000 Santa Cruz de Tenerife, Spain.
  • RICORS2040 (RD21/0005/0013), Instituto de Salud Carlos III, 28000 Madrid, Spain.
  • Navarrabiomed (Miguel Servet Foundation), Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.
  • Doctoral and Graduate School, University of La Laguna, 38200 San Cristóbal de La Laguna, Spain.

ORCID-Profile: Ernesto Martín-Núñez, Sergio Rodríguez-Ramos, Juan F Navarro-González

Förderung

  • ISCIII
  • FIISC
  • FCMG
  • Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain)
  • Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC; Canary Islands, Spain)
  • Miguel Servet Budget contract
  • Contratos pre-doctorales de formación en investigación en salud (PFIS contracts, Instituto de Salud Carlos III)

Zitieren

APA

Donate-Correa, J., Martín-Núñez, E., Hernández-Carballo, C., González-Luis, A., Mora-Fernández, C., Martín-Olivera, A., Rodríguez-Ramos, S., Cerro-López, P., López-Castillo, Á., Delgado-Molinos, A., López-Tarruella, V. C., & Navarro-González, J. F. (2024). FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease. International Journal of Molecular Sciences, 25(10), 5457. https://doi.org/10.3390/ijms25105457

Vancouver

Donate-Correa J, Martín-Núñez E, Hernández-Carballo C, González-Luis A, Mora-Fernández C, Martín-Olivera A, et al. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease. International Journal of Molecular Sciences. 2024;25(10):5457. doi:10.3390/ijms25105457

BibTeX
@article{DonateCorrea2024,
  author = {Donate-Correa, Javier and Martín-Núñez, Ernesto and Hernández-Carballo, Carolina and González-Luis, Ainhoa and Mora-Fernández, Carmen and Martín-Olivera, Alberto and Rodríguez-Ramos, Sergio and Cerro-López, Purificación and López-Castillo, Ángel and Delgado-Molinos, Alejandro and López-Tarruella, Victoria Castro and Navarro-González, Juan F},
  title = {FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5457},
  doi = {10.3390/ijms25105457}
}
Kostenlos starten →